JPMorgan Downgrades Amphastar Pharmaceuticals (AMPH) to Neutral from Overweight, Brings PT Down to $30

finance.yahoo.com/news/jpmorgan-downgrades-amphastar-pharmaceuticals-amph-151410316.html

JPMorgan Downgrades Amphastar Pharmaceuticals (AMPH) to Neutral from Overweight, Brings PT Down to $30
In This Article:
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On May 12, JPMorgan downgraded Amphastar…

This story appeared on finance.yahoo.com, 2025-07-10 15:14:10.
The Entire Business World on a Single Page. Free to Use →